Obstetrics and Gynecology International
Volume 2009 (2009), Article ID 364843, 8 pages
doi:10.1155/2009/364843
Clinical Study

Recombinant Activated Factor VII (rFVIIa) in the Management of Major Obstetric Haemorrhage: A Case Series and a Proposed Guideline for Use

Charlotte Bomken,1 Sue Mathai,1 Tina Biss,1 Andrew Loughney,2 and John Hanley1

1Department of Haematology, The Newcastle upon Tyne Hospitals NHS Trust, Freeman Hospital, Freeman Road, High Heaton, Newcastle-upon-Tyne NE7 7DN, UK
2Department of Obstetrics, The Newcastle upon Tyne Hospitals NHS Trust, Newcastle-upon-Tyne NE1 4LP, UK

Received 19 July 2009; Revised 14 October 2009; Accepted 1 December 2009

Academic Editor: Marc J. N. C. Keirse

Copyright © 2009 Charlotte Bomken et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Charlotte Bomken, Sue Mathai, Tina Biss, Andrew Loughney, and John Hanley, “Recombinant Activated Factor VII (rFVIIa) in the Management of Major Obstetric Haemorrhage: A Case Series and a Proposed Guideline for Use,” Obstetrics and Gynecology International, vol. 2009, Article ID 364843, 8 pages, 2009. doi:10.1155/2009/364843